Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001876758 | SCV002119086 | benign | Kabuki syndrome | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004529030 | SCV004109825 | uncertain significance | KMT2D-related disorder | 2022-11-07 | criteria provided, single submitter | clinical testing | The KMT2D c.3895C>T variant is predicted to result in the amino acid substitution p.Arg1299Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0052% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-49443476-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Fulgent Genetics, |
RCV005006106 | SCV005636044 | uncertain significance | Kabuki syndrome 1; Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome | 2024-03-12 | criteria provided, single submitter | clinical testing |